泊诺

Benova (Tianjin) Innovation Pharmaceutical Research is a Chinese pharmaceutical research and development company founded in 2018 as a wholly-owned subsidiary of Greenpine Pharma. The company serves as Greenpine's core R&D center, focusing on formulation process research, synthesis process development, drug analysis, clinical research, and drug registration. Benova operates a 1,500-square-meter R&D laboratory equipped with advanced analytical instruments and has successfully developed and registered several generic drugs. Its approved product portfolio includes Mycophenolate Sodium Enteric-coated Tablets, Exemestane Tablets, Ertapenem Sodium for Injection, and Levothyroxine Sodium Oral Solution. The company also collaborates with academic institutions to foster talent and advance pharmaceutical innovation.